InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.17), $0.01 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $2.54 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.